| Company Profile | Company Management |
|---|---|
|
Cardiff Scintigraphics Limited (CSL), also trading as i2c Pharmaceutical Services, is a spin-off company from Cardiff University, a Russell group university. Current sponsors of RDD online web based training module “Aerosol Deposition and Assessment of Pulmonary Drug Delivery” by Dr Stephen P. Newman. CSL was established in 1992 by scientists within the Welsh School of Pharmacy following several years of successfully conducting clinical gamma scintigraphy studies for the pharmaceutical industry. The founding scientific directors were Glyn Taylor, Stephen Farr and Ian Kellaway. CSL has built a wealth of knowledge in the area of drug formulation and device development and research. CSL has a nineteen year history as an independent company, meeting the diverse objectives and exacting standards of pharmaceutical development. CSL provides independent services to clients for development of pharmaceutical formulations and devices within laboratories at Cardiff. An alliance between CSL and Simbec Research Limited has existed since the mid-1990's and via this collaboration, human scintigraphy studies are conducted within the clinical pharmacology unit at Simbec. CSL has a dedicated team specializing in the niche services described on this site and endeavours to provide an efficient, reliable and effective service. |
 Professor Glyn Taylor Director of Research Email: glyn@i2cpharm.co.uk Phone: +44 (0)29 2075 7865  Dr Simon warren Research Manager Email: simon.warren@i2cpharm.co.uk Phone: +44 (0)29 2075 7865 |
